Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.

ABSTRACT:

SUBMITTER: Foureau D 

PROVIDER: S-EPMC8525140 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature